Researchers at The University of Texas Medical School at Houston believe they have uncovered the Achilles heel in the HIV virus: the HIV envelope protein gp120.

They have engineered antibodies with enzymatic activity (“abzymes”), which can attack the Achilles heel of the virus in a precise way. The next step is to confirm the theory in human clinical trials.